alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.44 Request for Use of Special Overdraft Service Translated From Japanese [Notice of Applicable Interest Rate Period] Application date: November 27, 2007 Name:          Hideki Anan, President & CEO
Global Hotline, Inc.
  Having confirmed the following conditions, I do hereby submit a request to Sumitomo Mitsui Banking Corporation for the use of the special overdraft service as outlined below. If you consent, please deposit the applicable amount to my (the applicants) account.  Amount
        ¥300,000,000Use
        Operating fundsDesired date of deposit
        November 30, 2007
        Expected date of final repayment
        December 28, 2007
  Payment details
        Payment cycle
        Payment date
        Number of payments
        Amount repaidmonths
        of each month
        times
        yenyenyenyenFinal due date
        
        300,000,000 yenMethod of interest payment
        Lump sum paymentHandling of bank holidays
        In the event that one of the dates above falls on a bank holiday, the payment shall be made on the following business day.
  Basic interest rate
        □   Short-term prime rate
        Applicable interest rate
        3.00% APR□Applicable interest rate period
        In the event that the applicable interest rate period is divided within the borrowing period and rates are adjusted accordingly:Starts:
Ends:
        1. Rates automatically adjusted on theeverymonths.
2. Notification made each time with Notice of Applicable Interest Rate Period.
  1.
        Payments shall be made according to the separately provided Special Overdraft Agreement (or, alternatively, the Specified Overdraft Agreement or the Special Overdrawing Account Agreement) by automatic transfer.
 2.
        Repayment of the borrowed funds shall be done according to the above payment details, regardless of the aforementioned original agreement.
 3.
        In the event that a partial early repayment is made and no particular indications are made, later repayments shall be made according to the above schedule, and the final date of repayment shall be moved up.
 4.
        When the market interest rate is applied as the basic interest rate, the application for the applicable interest rate period shall be made here.
  Request for Use of Special Overdraft Service (3-3) [Retain for 10 years  8032 17.4] Global Hotline, Inc.
[Federal Register Volume 87, Number 73 (Friday, April 15, 2022)]
[Notices]
[Page 22541]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-08087]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial 
Implementation Cooperative Agreement (U44 Clinical Trial Required).
    Date: May 25, 2022.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F52, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Lindsey M. Pujanandez, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4F52, 
Rockville, MD 20852, (240) 627-3206, <a href="/cdn-cgi/l/email-protection#dfb3b6b1bbacbaa6f1afaab5beb1beb1bbbaa59fb1b6b7f1b8b0a9"><span class="__cf_email__" data-cfemail="c2aeabaca6b1a7bbecb2b7a8a3aca3aca6a7b882acabaaeca5adb4">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: April 11, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-08087 Filed 4-14-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
CITY OF FRESNO, CALIFORNIA, et al., petitioners, v. Chris WILLIS, et al.

No. 17-67.

Supreme Court of the United States

Oct. 2, 2017.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
Julie GRANT, petitioner, v. UNITED STATES.

No. 17-5390.

Supreme Court of the United States

Oct. 2, 2017.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

November 26, 2008 Clifford W. Taylor,
Chief Justice
130031 & (78)(83) Michael F. Cavanag h
Elizabeth A. Weave r Marilyn Kell y Maura D. Corriga n Robert P. Young, Jr. PEOPLE OF THE STATE OF MICHIGAN, Stephen J. Markman, Plaintiff-Appellee/ J ustices Cross-Appellant,

v SC: 130031 COA: 256767 Oakland CC: 01-177766-FC LARRY A. MCGHEE, Defendant-Appellant/ Cross-Appellee.

________________ _________________________/

By order of April 13, 2007, th e parties were directed to file supplemental briefs. On order of the Court, the supplemental brie fs having been received, the application for leave to appeal the November 8, 2005 ju dgment of the Court of Appeals and the application for leave to appeal as cross-appellant are again considered, and they are DENIED, because we are not pe rsuaded that the questions pr esented should be reviewed by this Court.

s1119 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

November 26, 2008

Clerk
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3880 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
                                H. R. 3880

 To amend the Internal Revenue Code of 1986 to allow the deduction for 
       health insurance costs in computing self-employment taxes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 23, 2019

Mr. Delgado (for himself and Mr. Joyce of Pennsylvania) introduced the 
 following bill; which was referred to the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
 To amend the Internal Revenue Code of 1986 to allow the deduction for 
       health insurance costs in computing self-employment taxes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Tax Fairness for the Self-Employed 
Act of 2019''.

SEC. 2. DEDUCTION FOR HEALTH INSURANCE COSTS ALLOWED IN COMPUTING SELF-
              EMPLOYMENT TAXES.

    (a) In General.--Subsection (l) of section 162 of the Internal 
Revenue Code of 1986 is amended by striking paragraph (4) and by 
redesignating paragraph (5) as paragraph (4).
    (b) Effective Date.--The amendment made by this section shall apply 
to taxable years beginning after the date of the enactment of this Act.
                                 <all>
```
In Re Nathanael Lenard REYNOLDS, petitioner.

No. 17-5012.

Supreme Court of the United States

Oct. 2, 2017.

Motion of petitioner for leave to proceed *in forma pauperis* denied, and the petition for writ of mandamus dismissed. See Rule 39.8.
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                           2,361
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                          16,823
<DEPRECIATION>                                   3,146
<TOTAL-ASSETS>                                  19,186
<CURRENT-LIABILITIES>                                0
<BONDS>                                         15,684
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                       2,288
<TOTAL-LIABILITY-AND-EQUITY>                    19,186
<SALES>                                              0
<TOTAL-REVENUES>                                 6,465
<CGS>                                                0
<TOTAL-COSTS>                                    6,130
<OTHER-EXPENSES>                                -4,562
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 130
<INCOME-PRETAX>                                  4,671
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              4,671
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,671
<EPS-BASIC>                                   250.24<F1>
[EPS-BASIC]                                   250.24<F1>
<FN>
<F1>Net income per limited partner unit.
</FN>


</TABLE>
[Federal Register Volume 66, Number 126 (Friday, June 29, 2001)]
[Notices]
[Pages 34699-34700]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-16338]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning

[[Page 34700]]

individuals associated with the grant applications, the disclosure of 
which would constitute a clearly unwarranted invasion of personal 
privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Minority Undergraduate Biomedical Education 
Program.
    Date: July 13, 2001.
    Time: 8:00 am to 4:00 pm.
    Agenda: To review and evaluate grant applications.
    Place: 5520 Wisconsin Avenue, Chevy Chase, MD 20815.
    Contact Person: Roy L White, Review Branch, NIH, NHLBI, 
Rockledge Building II, 6701 Rockledge Drive, Room 7196, Bethesda, MD 
20892, 301-435-0291.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: June 22, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-16338 Filed 6-28-01; 8:45 am]
BILLING CODE 4140-01-M
# C_2011179EN.01000602.xml

| 18.6.2011 | EN | Official Journal of the European Union | C 179/6 |
| --- | --- | --- | --- |

18.6.2011

EN

Official Journal of the European Union

C 179/6

---

Judgment of the Court (Eighth Chamber) of 14 April 2011 — European Commission v Grand Duchy of Luxembourg

(Case C-390/10) (1)

1

(Failure of a Member State to fulfil obligations - Directive 2007/36/EC - Exercise of certain rights of shareholders in listed companies - Failure to transpose within the period prescribed)

2011/C 179/09

Language of the case: French

Parties

Parties

Applicant: European Commission (represented by: G. Braun and de Schietere de Lophem, acting as Agents)

Applicant:

Defendant: Grand Duchy of Luxembourg (represented by: C. Schiltz, acting as Agent)

Defendant:

Re:

Re:

Failure of a Member State to fulfil obligations — Failure to take or communicate, within the prescribed period, the measures necessary to comply with Directive 2007/36/EC of the European Parliament and of the Council of 11 July 2007 on the exercise of certain rights of shareholders in listed companies (OJ L 184, p. 17)

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Declares that, by failing to adopt, within the prescribed period, the laws, regulations and administrative provisions necessary to comply with Directive 2007/36/EC of the European Parliament and of the Council of 11 July 2007 on the exercise of certain rights of shareholders in listed companies, the Grand Duchy of Luxembourg has failed to fulfil its obligations under that directive; |
| --- | --- |

1.

Declares that, by failing to adopt, within the prescribed period, the laws, regulations and administrative provisions necessary to comply with Directive 2007/36/EC of the European Parliament and of the Council of 11 July 2007 on the exercise of certain rights of shareholders in listed companies, the Grand Duchy of Luxembourg has failed to fulfil its obligations under that directive;

| 2. | Orders the Grand Duchy of Luxembourg to pay the costs. |
| --- | --- |

2.

Orders the Grand Duchy of Luxembourg to pay the costs.

---

(1)  OJ C 274, 9.10.2010.

1

---
Mario Donta GAULDIN, petitioner, v. Scott KERNAN, Secretary, California Department of Corrections and Rehabilitation.

No. 16-9442.

Supreme Court of the United States

Oct. 2, 2017.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
W.A. GRIFFIN, petitioner, v. COCA-COLA REFRESHMENTS USA, INC., et al.

No. 17-1244.

Supreme Court of the United States

May 14, 2018.

Petition for writ of certiorari before judgment to the United States Court of Appeals for the Eleventh Circuit denied.
Stephen O. CALLAGHAN, petitioner, v. WEST VIRGINIA JUDICIAL INVESTIGATION COMMISSION.

No. 17-54.

Supreme Court of the United States

Oct. 2, 2017.

Petition for writ of certiorari to the Supreme Court of Appeals of West Virginia denied.
# L_2006267EN.01004801.xml

| 27.9.2006 | EN | Official Journal of the European Union | L 267/48 |
| --- | --- | --- | --- |

27.9.2006

EN

Official Journal of the European Union

L 267/48

---

Corrigendum to Decision No 1/2006 of the EC-Turkey Customs Cooperation Committee of 26 September 2006 laying down detailed rules for the application of Decision No 1/95 of the EC-Turkey Association Council (2006/646/EC)

(
  Official Journal of the European Union L 265 of 26 September 2006
  )

On the cover page, on page 18 in the title, and on page 32, in the concluding formula:

for:

‘
  26 September 2006
  ’

read:

‘
  26 July 2006
  ’.

---
U.S. COMMODITY FUTURES TRADING COMMISSION 

ENERGY AND ENVIRONMENTAL MARKETS ADVISORY COMMITTEE 

NOVEMBER 13, 2023 AGENDA 

9:00 a.m. Opening Remarks

9:30 a.m. Panel 1: The State of the Power Markets

A discussion exploring the United States’ current and future power needs, the 

impact on other energy markets, and the role of derivatives markets in facilitating 

the expansion of these markets. 

Lead Participant:

• Sharon Theodore, Electric Power Supply Association

10:30 a.m. Panel 2: Update from EEMAC Role of Metals Markets in Transitional 

Energy Subcommittee Update from EEMAC Physical Energy Infrastructure 

Subcommittee 

The EEMAC Role of Metals Markets in Transitional Energy Subcommittee will 

give an overview of its works and the status of its planned report. 

Lead Participant: 

• Ian Lange, Chair of the EEMAC Role of Metals Markets in Transitional 

Energy Subcommittee

11:00 a.m. Panel 3: Update from EEMAC Physical Energy Infrastructure 

Subcommittee 

The EEMAC Physical Energy Infrastructure Subcommittee will give an overview 

of its works and the status of its planned report. 

Lead Participant: 

• Tim Fitzgerald, Chair of the EEMAC Physical Energy Infrastructure 

Subcommittee

11:30 a.m. Closing Remarks

12:00 p.m. Adjourn Meeting
Exhibit 31.1

CERTIFICATION

I, Martin Nielson, certify that:

1.  I have  reviewed  this  annual  report  on  Form  10-K  of  Pacific  Magtron
International Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact  necessary to make the statements
made, in light of the  circumstances  under which such statements were made, not
misleading with respect to the period covered by this report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.  The  registrant's  other  certifying  officers  and  I are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

      a.  designed  such  disclosure  controls  and  procedures,  or caused such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure that  material  information  relating to the  registrant,  including  its
consolidated subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

      b. evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report my conclusion about the effectiveness of
the disclosure  controls and procedures,  as of the end of the period covered by
this report based on such evaluation; and


      c.  disclosed  in this  report  any  change in the  registrant's  internal
control over financial  reporting  that occurred  during the  registrant's  most
recent fiscal quarter (the registrant's  fourth fiscal quarter in the case of an
annual  report)  that  has  materially  affected,  or is  reasonably  likely  to
materially affect, the registrant's  internal control over financial  reporting;
and

5. The registrant's other certifying officers and I have disclosed, based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent function):

      a. all significant  deficiencies and material  weaknesses in the design or
operation of internal  controls over  financial  reporting  which are reasonably
likely  to  adversely  affect  the  registrant's  ability  to  record,  process,
summarize and report financial information; and

      b. any fraud,  whether or not material,  that involves management or other
employees who have a significant role in the registrant's internal controls over
financial reporting.

Date: April 20, 2005

By: Martin Nielson
    Chief Executive Officer
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEET AS OF SEPTEMBER 30, 1999 AND THE CONDENSED
CONSOLIDATED STATEMENT OF OPERATIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30,
1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                             161
<SECURITIES>                                         0
<RECEIVABLES>                                  130,701
<ALLOWANCES>                                    19,721
<INVENTORY>                                    436,666
<CURRENT-ASSETS>                               567,944
<PP&E>                                       1,280,380
<DEPRECIATION>                                 489,182
<TOTAL-ASSETS>                               1,504,760
<CURRENT-LIABILITIES>                          382,013
<BONDS>                                      1,275,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           711
<OTHER-SE>                                    (494,490)
<TOTAL-LIABILITY-AND-EQUITY>                 1,504,760
<SALES>                                      1,398,102
<TOTAL-REVENUES>                             1,398,102
<CGS>                                        1,022,579
<TOTAL-COSTS>                                1,022,579
<OTHER-EXPENSES>                                 1,834
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              75,662
<INCOME-PRETAX>                                114,743
<INCOME-TAX>                                    41,400
<INCOME-CONTINUING>                             73,343
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    73,343
<EPS-BASIC>                                       1.32
<EPS-DILUTED>                                     1.28


</TABLE>
Lazaro ROBBIO, petitioner, v. UNITED STATES.

No. 17-8182.

Supreme Court of the United States

April 16, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
In Re Jane DOE, petitioner.

No. 17-8302.

Supreme Court of the United States

June 4, 2018.

Petition for writ of mandamus and/or prohibition denied.